New treatment approaches for Alzheimer’s disease: preclinical studies and clinical trials centered on antidiabetic drugs-Reference-Cited by-同舟云学术

New treatment approaches for Alzheimer’s disease: preclinical studies and clinical trials centered on antidiabetic drugs

Published:2022-01-02 Issue: Volume: Page:1-19
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Katsenos Andreas P.¹²,Davri Athena S.¹,Simos Yannis V.¹²^ORCID,Nikas Ilias P.³,Bekiari Chryssa⁴,Paschou Stavroula A.⁵,Peschos Dimitrios¹²^ORCID,Konitsiotis Spyridon⁶,Vezyraki Patra¹,Tsamis Konstantinos I.¹²⁶^ORCID

Affiliation:

1. Department of Physiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece

2. Nanomedicine and Nanobiotechnology Research Group, University of Ioannina, Greece

3. School of Medicine, European University Cyprus, Nicosia, Cyprus

4. Laboratory of Anatomy and Histology, school of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

5. Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

6. Department of Neurology, University Hospital of Ioannina, Ioannina, Greece

Funder

European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2022.2022122

Reference168 articles.

1. A Century of Alzheimer's Disease

2. 2021 Alzheimer's disease facts and figures